Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Bevacizumab 21Paclitaxel 19Carboplatin 15pembrolizumab 14Specimen Handling 14liposomal doxorubicin 12Magnetic Resonance Spectroscopy 12Cyclophosphamide 11olaparib 10Gemcitabine 10fludarabine 9Topotecan 8Biopsy 8Fulvestrant 7niraparib 6Nivolumab 6palbociclib 5Taxes 5Immunoglobulin G 5Doxorubicin 5Disulfides 5aldesleukin 4trastuzumab deruxtecan 3mirvetuximab soravtansine 3binimetinib 3Oxaliplatin 3Cisplatin 3AZD5305 31-dodecylpyridoxal 3ulixertinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian Neoplasms × Etodolac × 30 days × Clear all
NCT05429970 2026-05-18

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting
35 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡